Coronavirus (COVID-19) Preparedness Information Learn More
Our hospital is committed to providing the highest quality care and ensuring the safety of our patients, employees, providers, volunteers and visitors. We are continuing to monitor the evolving situation with the coronavirus (COVID-19) and are taking the necessary steps to ensure we are fully prepared to care for patients, in accordance with guidance from the Centers for Disease Control and Prevention (CDC) and in partnership with our local and state health departments.
Below are a number of resources to help educate you and your family on COVID-19. For more information on the virus, please contact the Wapello County Public Health Department.
We know there are a lot of questions about the emerging COVID-19 vaccines. Our goal is to keep you informed as vaccines are approved and rolled out for our workforce, patients and community in the weeks ahead.We have created a list of common questions about the COVID-19 vaccines based on current knowledge and understanding. These questions will continue to evolve with time, so we encourage you to check back frequently for the most up-to-date information.
Common Questions about COVID-19 Vaccines:
We are in the process of distributing the vaccine in accordance with prioritization guidance from the Centers for Disease Control and Prevention (CDC), the federal government and our state health departments. We are currently in phase 1B of vaccination, which includes individuals over the age of 65. Those who qualify for vaccination within phase 1B should check the message at the top of the page for the most up to date information on vaccine availability.
The U.S. vaccine safety system ensures that all vaccines are as safe as possible. Safety is the top priority while federal partners work to make the COVID-19 vaccines. Despite what the name may suggest, “Operation Warp Speed” does not mean that manufacturers were able to skip steps or cut corners in the vaccine development process. Instead, after development of the vaccine, manufacturers took a secured risk and overlapped the study, manufacturing and distribution phases. The FDA committed to giving these vaccinations priority (not rushed) review at all phases of the studies, which helped speed up the overall process. Ongoing monitoring of vaccine effectiveness and side effect reports will continue to be evaluated by the FDA and the manufacturers.
Yes. For several reasons, a mask and other proven methods of preventing COVID-19 (hand hygiene and social distancing) are still important even after receiving the vaccine. It typically takes a few weeks for the body to build immunity after vaccination. That means it is possible that a person could be infected with the virus that causes COVID-19 just before or just after vaccination. This is because the vaccine has not had enough time to provide protection.
Yes. At this time, the vaccine is recommended even if you previously tested positive for COVID-19. There is not enough information currently available to say if or for how long after infection someone is protected from getting COVID-19 again; this is called natural immunity. Early evidence suggests natural immunity from COVID-19 may not last very long, but more studies are needed to better understand this. More information will be shared as it becomes available.
Due to the severe health risks associated with COVID-19 and the fact that re-infection with COVID-19 is possible, people who have had COVID-19 greater than 90 days ago should proceed with getting the vaccine. Due to limited vaccine supply, if you have had COVID-19 within the last 90 days, your likelihood of reinfection is low enough during this time period that you can wait to get the vaccine until you hit the 90-day mark after being sick.
No. The vaccine is NOT a live vaccine, and it is NOT possible to contract COVID-19 from receiving the vaccine. Some people experience side effects from the vaccine, such as headache, muscle pain, or fever – but that does not mean you have COVID-19. It means your body is working to build the necessary immunity against the virus, which is a good thing.
The most common adverse reactions reported have been fatigue, headache, fever/chills and joint pain. This means your body is working to build the necessary immunity against the virus.
You can read more in Pfizer’s FDA Briefing Document and Moderna’s FDA Briefing Document about the side effects reported among the vaccine study participants.
The COVID-19 vaccine is not indicated for children younger than 16 years old at this time.
The American College of Obstetricians and Gynecologists (ACOG) recommends that COVID-19 vaccines should not be withheld from pregnant individuals. It is important to note that the COVID-19 vaccines currently available have not been tested in pregnant women, so there is no safety data specific to use in pregnancy. Pregnant women should make an informed decision after discussing with their healthcare provider.
For both the Pfizer and Moderna vaccine, two doses are required. The second dose of the Pfizer vaccine should be administered 21 days after the first dose. The second dose of the Moderna vaccine should be administered 28 days after the first dose. It is very important to note that the second dose must be from the same manufacturer as the first dose.
While it is recommended that you receive the second dose as soon as feasible after day 21 or day 28, we understand that it might not be possible to receive it on the desired date. This could be due to multiple reasons. Please keep the following in mind if you cannot receive the second vaccine dose on the desired date:
Similar to the flu vaccine, it typically takes a few weeks for the body to build immunity after vaccination. That means it’s possible a person could be infected with the virus that causes COVID-19 just before or just after vaccination and get sick. This is because the vaccine has not had enough time to provide protection. As a general rule, the vaccine is considered effective about two weeks after the second dose, according to the manufacturers. There is evidence that the first dose will begin providing some immunity, but it is still very important to receive the second dose for optimal results.
We do not recommend waiting for a specific manufacturer. Both Pfizer and Moderna vaccines have similar efficacy and potential side effects, and have shown decreased disease severity in the small numbers of study participants who contracted COVID-19 after receiving the vaccine. Both manufacturers require two doses. It is important to remember that the second dose you receive must be from the same manufacturer. Early defense is better than no defense against COVID-19.
Ottumwa Regional Health Center is committed to providing the highest quality care and ensuring the safety of our patients, employees, providers, volunteers and visitors. We are working closely with the Iowa Department of Public Health and following guidance from the Centers for Disease Control and Prevention (CDC) to ensure our hospital is prepared with the appropriate plans to detect, protect and respond should anyone in our community contract or be exposed to the novel coronavirus (2019-nCoV).
While we have not evaluated or treated any patients with this virus at our hospital to date, Ottumwa Regional Health Center has taken the following measures to prepare out of an abundance of caution, in accordance with CDC guidelines:
Importantly, all of the above are standard operating protocols that are in place year-round to help ensure the health and well-being of everyone who enters our hospital.
We want to assure our community that our providers and clinical teams are well-trained and prepared to manage outbreaks of viruses and infectious diseases, including the coronavirus. For more information, contact the Iowa Department of Public Health or visit the Centers for Disease Control and Prevention website.